Pharma industry wants Budget to announce incentives for conducting R&D

"An increase in the budgetary allocation from the current 1.8 per cent of the GDP to 2.5-3 per cent, as envisaged in the National Health Policy 2017 along with a separate allocation for the bio-pharmaceutical sector R&D is imperative," Organisation of Pharmaceutical Producers of India (OPPI) President S Sridhar told PTI.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3KM82Io
via IFTTT